Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 52

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 5
Chunk 52
---
 offset by (i) approximately $62,000 decrease in prepaid expenses and other current
assets, (ii) approximately $0.5 million increase in other payables and accrued liabilities mainly resulting from accrued professional
fees, (iii) approximately $80,000 increase in taxes payable, (iv) approximately $1.3 million in change in fair value of prepaid forward
purchase liabilities, (v) approximately $2.6 million increase in loss on settlement of prepaid forward contracts, (vi) approximately
$0.6 million in loss on debt settlement, and (vii) approximately $0.3 million net cash provided by operating activities from discontinued
operations.

Net
cash used in operating activities was approximately $1.5 million for the year ended December 31, 2022 and was primarily attributable
to (i) approximately $25.0 million in net loss from continuing operations as discussed above, (ii) approximately $48,000 in deferred
tax benefits, (iii) approximately $38,000 decrease in taxes payable, (iv) approximately $43,000 payments on operating lease liability,
and (v) approximately $1.4 million net cash used in operating activities from discontinued operations, offset by (i) approximately $0.1
million decrease in accounts receivables, (ii) approximately $1.6 million decrease in other receivables mainly resulting from the collection
of our investment income, (iii) approximately $1.1 million increase in other payables and accrued liabilities mainly resulting from accrued
professional fees, (iv) approximately $12.9 million in change in fair value of prepaid forward purchase liabilities, (v) approximately
$2.8 million in provision for doubtful accounts due to write-off of the balance of receivable from divestment from BPT, an unrelated
third party and the balance from loan to PT total Prima Indonesia, (vi) approximately $5.2 million
in earn out payment upon assessing the fair value of the Earnout Share,

Investing
Activities

Net
cash used in investing activities was approximately $0.1 million for the year ended December 31, 2024, which was primarily attributable
to approximately $0.1 million in purchase of equipment and intangible assets, and approximately $45,000 loan to third parties, offset
by approximately $16,000 cash acquired from the Fortress Cove Acquisition.

There
was no net cash provided by investing activities for the year ended December 31, 202